# A review of HIV prevention among young injecting drug users: A guide for researchers

## TL;DR

This paper reviews HIV prevention efforts for young drug users to see if they reduce risky behaviors.

## Contribution

The paper provides a review of existing HIV prevention programs targeting young injecting drug users.

## Key findings

- Half of new HIV infections are linked to injection drug use.
- The average age for starting injecting drug use is 20 years.
- The paper examines the effectiveness of HIV prevention programs in reducing risk behaviors.

## Abstract

Young people aged 15–24 years account for fifty percent of all new AIDS cases worldwide. Moreover, half of all new HIV infections are associated with injection drug use. The average age for initiation into injecting drug use is 20 years of age. This paper investigates whether HIV prevention programs have reduced risk behaviours in young people.